𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial

✍ Scribed by Alan J. Kivitz; Maria W. Greenwald; Stanley B. Cohen; Adam B. Polis; Daryl K. Najarian; Mary E. Dixon; Robert A. Moidel; Jerry A. Green; Herbert S. B. Baraf; Richard A. Petruschke; Alan K. Matsumoto; Gregory P. Geba; for the Protocol 085; study investigators


Book ID
109128343
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
218 KB
Volume
52
Category
Article
ISSN
0002-8614

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy and safety of four doses of lum
✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 3 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m